Hemostasis Analyzers Market Statistics Report 2028

report image

Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Laboratory Analyzer (Automated Systems, Semi-Automated Systems, and Manual Systems) and Point-of-Care Testing Systems], Test [Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, and Others], and End User (Hospitals/Clinics, Independent Diagnostic Laboratories, Home Care Setting, and Others)

Publication Month: Dec 2021 | Report Code: TIPRE00016709 | No. of Pages: 188 | Category: Medical Device | Status: Published

The hemostasis analyzers market is projected to reach US$ 6,490.24 million by 2028 from US$ 3,440.66 million in 2021; it is expected to register a CAGR of 9.5% from 2021 to 2028.

Hemostasis analyzers provide a quick and easy measurement of blood platelet levels. A coagulation test could help detect and prevent blood clots that could cause a heart attack. A coagulation analyzer can measure the speed of the coagulation pathway and the amounts of thrombolin and thromboplastin in less than a few minutes.Cardiovascular diseases (CVDs) are likely to remain the most significant cause of morbidity and mortality worldwide. The CVDs are disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Some lifestyle-related issues that lead to cardiovascular diseases and difficulties are tobacco use, unhealthy diet, and physical inactivity. They increase the risk of heart attacks and strokes. Other risk factors for cardiovascular diseases are high blood pressure, diabetes, and increased cholesterol levels. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally.

Strategic Insights

Report Coverage - Hemostasis Analyzers Market
Report CoverageDetails
Market Size Value inUS$ 3,440.66 million in 2021
Market Size Value byUS$ 6,490.24 million by 2028
Growth rateCAGR of 9.5% from 2021 to 2028.
Forecast Period2021-2028
Base Year2021
No. of Pages188
No. of Tables111
No. of Charts & Figures77
Historical data availableYes
Segments coveredProduct Type, Test, and End User
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Lucrative Regions for Hemostasis Analyzers Market

Lucrative Regions for Hemostasis Analyzers Market

Get more information on this report :

Market Insights
Rise in Geriatric Population to Drive Hemostasis Analyzers Market

Older people are prone to heart diseases due to weak immunity and other health problems. General aging factors lead to stiffening heart and blood vessels that result in heart disorders. As the age grows, the systolic blood pressure also rises, leading to cardiovascular diseases (CVDs). Thus, in people aged 75 years and above, high blood pressure is a common risk factor for heart conditions. Coronary artery disease and heart failure are the others. Although the incidence of arrhythmias encompasses people of all age groups, it is rising significantly among the geriatric population.

According to the Global Ageing 2019 survey, the world's population of 65 years and above totaled 703 million in 2019. The senior demographic is expected to double to 1.5 billion people by 2050. The frequency of one person with age 65 or more is likely to increase from 1 in every 11 inhabitants in 2019 to 1 in every 6 inhabitants by 2025. This demographic is more susceptible to CVDs, such as arrhythmias. Similarly, according to the World Health Organization (WHO), the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. As per the report "Older Americans 2016: Key Indicators of Well-Being" by the Federal Interagency Forum on Aging-Related Statistics, 35.8% of individuals aged 85 and above had a mild or extreme cognitive disorder. Moreover, according to the United Nation's World Population Ageing 2017 report, in 2017, 962 million people were aged 60 years or over worldwide, and the number is expected to reach nearly 2.1 billion by 2050.

The elderly population is more prone to atypical presentations, comorbid conditions, and unfavorable outcomes. The primary reason for the diseases is related to the structural and functional changes in the cardiovascular system associated with aging. The rise in the global geriatric population is leading to a surge in cardiovascular diseases, which, in turn, is propelling the demand for hemostasis analyzers



Product Type-Based Insights

Based on product type, the hemostasis analyzers market is further segmented into laboratory analyzers and point-of-care testing systems. In 2021, the laboratory analyzers segment is held the largest share of the market, and the point-of-care testing systems segment is estimated to register the highest CAGR during 2021–2028.

Hemostasis Analyzers Market Share, by Product Type – 2021 and 2028


Hemostasis Analyzers Market Share, by Product Type – 2021 and 2028

Get more information on this report :

Test-Based Insights

Based on test, the market is segmented into activated partial thromboplastin time, D-Dimer test, fibrinogen test, prothrombin time test, and others. In 2021, the activated partial thromboplastin time segment held the largest share of the market. The prothrombin time test segment is expected to register the highest CAGR in the market during 2021–2028.

End User-Based Insights

Based on end users, the market is segmented into hospitals/clinics, independent diagnostic laboratories, home care settings, and others. In 2021, the hospitals/clinics segment accounted for the largest share of the market. The independent diagnostic laboratories segment is expected to register the highest CAGR in the market during 2021–2028.

Companies operating in the hemostasis analyzers market emphasize adopting the strategy of product innovations to meet the evolving customer demands worldwide, which also permits them to maintain their brand name in the global market.

Hemostasis Analyzers Market – Segmentation

The Hemostasis Analyzers market is segmented based on product type, test, and end-user. Based on product type, the hemostasis analyzers market is segmented into laboratory analyzers and point-of-care testing systems. Based on test, the market is further segmented into activated partial thromboplastin time, D-Dimer test, fibrinogen test, prothrombin time test, and others. Based on end-user, the market is segmented into hospitals/clinics, independent diagnostic laboratories, home care settings, and others. In terms of geography, the hemostasis analyzers market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM)

Company Profiles

  • Siemens AG
  • Instrumentation Laboratory
  • Abbott
  • Sysmex Corporation
  • Nihon Kohden Corporation
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Diagnostica Stago
  • Helena Laboratories
  • International Technidyne Corporation.

Frequently Asked Questions

Hemostasis analyzers are medical devices that are used to measure the clotting time of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners.
The factors driving and restraining the hemostasis analyzers market in the coming years include the high prevalence of cardiovascular diseases and the rise in the geriatric population. However, the high cost of a fully automated hemostasis analyzer is likely to hamper the market's growth.
The hemostasis analyzers market majorly consists of the players such as Siemens AG, Instrumentation Laboratory, Abbott, Sysmex Corporation, Nihon Kohden Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Diagnostica Stago, Helena Laboratories, International Technidyne Corporation are amongst others.
The global hemostasis analyzers market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In the North America region, the market for hemostasis analyzers market is primarily held by the US among the other countries. The growth of the hemostasis analyzers market in the United States is expected to grow owing to increasing organic developments by the market players in the market, rising awareness among consumers for treatment, and an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases.
The global hemostasis analyzers market based on product is segmented into product type [laboratory analyzer (automated systems, semi-automated systems, and manual systems) and point-of-care testing systems. In 2021, the laboratory analyzer segment held the largest share of the market by product and point-of-care testing systems is expected to witness the fastest CAGR during 2021 to 2028.
The Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to the rising development in the pharmaceutical sector. Also, the rise in the incidence of cardiovascular diseases is likely to provide more significant growth opportunities to the market players in the coming years is likely to boost the growth of the market in the Asia Pacific region.

The List of Companies - Hemostasis Analyzers Market

  1. Siemens AG
  2. Instrumentation Laboratory
  3. Abbott
  4. Sysmex Corporation
  5. Nihon Kohden Corporation
  6. Thermo Fisher Scientific Inc.
  7. Roche Diagnostics
  8. Diagnostica Stago
  9. Helena Laboratories
  10. International Technidyne Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the hemostasis analyzers market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global hemostasis analyzers market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00016709
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount